Vyome Holdings, Inc. (HIND)
Vyome Holdings, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Cambridge, MA, US. The stock last traded at $2.26, up 0.44% on the session, giving a market capitalisation of $15.9M. On trailing twelve-month figures it carries a trailing P/E of -0.06, a net margin of -985.5%. Its beta of 1.49 implies it has historically moved more than the broad market.
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
Vyome Holdings, Inc. is most often compared with the following Healthcare names: